Recombinant N-Cadherin anticorps (full length)
Aperçu rapide pour Recombinant N-Cadherin anticorps (full length) (ABIN7877741)
Antigène
Voir toutes N-Cadherin (CDH2) AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
Clone
-
-
Épitope
- full length
-
Fonction
- Recombinant CDH2 Antibody / N-Cadherin / CD325 (azide and preservative free)
-
Purification
- Protein A affinity chromatography
-
Immunogène
- Recombinant full-length human protein was used as the immunogen for the recombinant CDH2 antibody.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal dilution of the recombinant CDH2 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Agent conservateur
- Azide free
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store the recombinant CDH2 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- N-Cadherin (CDH2) (Cadherin 2 (CDH2))
-
Autre désignation
- CDH2
-
Sujet
- Recognizes a protein of ~140 kDa, identified as N-Cadherin (NCAD), also known as CD325 and CDH2. NCAD is a member of the Cadherin superfamily, and consists of five extracellular repeats, a transmembrane domain and a cytoplasmic domain. CD325 deficient mice die at day 10 of gestation and embryos display major heart defects and malformed neural tubes and somites. Consistent with this, CD325 has been implicated in several aspects of cardiac development including the precardiac mesoderm, establishment of left-right symmetry and cardiac looping morphogenesis. Furthermore, CD325 is normally involved in inducing cell cycle arrest and its expression is frequently deregulated in cancer cells.Studies have linked N-cadherin to cancer metastasis by showing the aggressive tumor cells had preferentially turned on N-cadherin as opposed to E- or P-cadherin.
-
UniProt
- P19022
-
Pathways
- Regulation of Muscle Cell Differentiation, Cell-Cell Junction Organization, Synaptic Membrane
Antigène
-